Tsf Investments (TSFINV)
Asset PlayFairStock Score: 36/100 — MIXED
Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹415.45 |
| Market Cap | ₹9,168.64 Cr |
| P/E Ratio | 18.98 |
| ROCE | 2.27% |
| ROE | —% |
| Dividend Yield | 3.04% |
| Profit Growth | -22.3% |
| Debt/Equity | 0.04 |
| Sales Growth | 70.9% |
| Promoter Holding | 55.01% |
| 52-Week Range | ₹331.7 — ₹701.5 |
| Sector | Finance |
| Book Value | ₹271.63 |
Strengths
- Low leverage: Debt/Equity of 0.05 indicates a conservative balance sheet.
- Latest quarter profitable: Sales ₹258 Cr and Net Profit ₹105 Cr show current earning capacity.
- Promoter holding of 55.01% aligns management with minority shareholders.
- Dividend yield of 1.67% provides some income while waiting for value realization.
Concerns
- Profit growth is negative at -2.53% despite a 693.34% sales surge, raising questions about earnings quality.
- ROCE of only 2.27% suggests poor return on invested capital for an investment company.
- Piotroski F-Score of 4/9 signals weak fundamental health.
- P/B of 1.54 and P/E of 19.04 leave limited margin of safety against book value of ₹265.83.
AI Analysis
At ₹410.60, TSF Investments gets my attention as an investment company, but attention and enthusiasm are different. Mr. Market is currently asking 19.04 times earnings and 1.54 times book value. For an investment company, book value is the anchor: ₹265.83 per share. Paying nearly 1.5 times that means I must believe the underlying assets are worth far more, or future returns will expand. I don't see proof yet. Revenue jumped 693.34% in the latest quarter, with sales of ₹258 Cr and net profit of ₹105 Cr. That sounds wonderful, but full-year profit is down 2.53%. A single quarter cannot build a margin of safety. ROCE is only 2.27% — not the kind of return on capital Buffett seeks. Debt is low at 0.05, which is good, and the 1.67% dividend gives me some compensation while I wait. Promoters own 55.01%, so interests appear aligned. But the Piotroski F-Score is 4/9, a weak health score. A 19 P/E with falling profits and poor return on capital does not offer a compelling margin of safety. In Graham's language, this is not a 'buy business, not ticker.' I would wait for either a much lower price near book value or evidence that earnings growth becomes consistent. For now, TSF looks like a mixed asset play, not a compounding machine. I'd keep it on my watch list, not in my wallet.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer